Benutzer: Gast  Login
Titel:

Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.

Dokumenttyp:
journal article
Autor(en):
Kieseier, BC; Stüve, O; Dehmel, T; Goebels, N; Leussink, VI; Mausberg, AK; Ringelstein, M; Turowski, B; Aktas, O; Antoch, G; Hartung, HP
Abstract:
BACKGROUND Neuromyelitis optica (NMO) is an autoimmune disease of the central nervous system in which aberrant antibody responses to the astrocytic water channel aquaporin 4 have been described. Experimental evidence is emerging that NMO is partly driven by the proinflammatory cytokine interleukin 6 (IL-6), which propagates the survival of disease-specific B cell subclasses, and deviates CD4+ T helper cell differentiation toward IL-17-producing T helper 17 cells. Tocilizumab is a recombinant hum...     »
Zeitschriftentitel:
Arch Neurol
Jahr:
2012
Seitenangaben Beitrag:
1-4
Sprache:
eng
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/23266885
Print-ISSN:
0003-9942
TUM Einrichtung:
Neurologische Klinik und Poliklinik
 BibTeX